Beam Therapeutics Stock Target Price and Analyst Consensus
| BEAM Stock | USD 27.14 0.58 2.09% |
The current analyst and expert consensus on Beam Therapeutics is Strong Buy, with 10 strong buy opinions. The current projected Beam Therapeutics target price consensus is 45.93 with 17 analyst opinions. Check out Macroaxis Advice on Beam Therapeutics to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. To learn how to invest in Beam Stock, please use our How to Invest in Beam Therapeutics guide.The most common way Beam Therapeutics analysts use to provide recommendation to the public is financial statements analysis. Many experts also interview Beam Therapeutics executives and customers to further validate their buy or sell advice. Beam Therapeutics buy-or-sell recommendation module provides average expert sentiment on the projected Beam Therapeutics target price to derive its highest and lowest estimates based on projected price volatility of 4.6644.
Lowest Forecast 41.8 | Highest Forecast 50.98 | Target Price 45.93 |
It's important to approach Beam Therapeutics' target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.
Steps to utilize Beam Therapeutics price targets
Beam Therapeutics' stock target price is an estimate of its future price, usually made by analysts. Using Beam Therapeutics' target price to determine if it is a suitable investment can be done through the following steps:- Look at Beam Therapeutics' target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
- Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
- Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
- Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Beam Therapeutics' stock is likely to perform well.
- Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Additional Beam Therapeutics Value Projection Modules
Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Beam Therapeutics is a key component of Beam Therapeutics valuation and have some predictive power on the future returns of a Beam Therapeutics.Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | ESG Investing Invested few shares | |
 | Compulsion Invested over 60 shares | |
 | Robots And Drones Invested one share | |
 | Macroaxis Index Invested over 40 shares | |
 | Artificial Intelligence Invested over 300 shares | |
 | IT Invested over 100 shares | |
 | Baby Boomer Prospects Invested one share | |
 | Power Assets Invested over 200 shares |
Check out Macroaxis Advice on Beam Therapeutics to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. To learn how to invest in Beam Stock, please use our How to Invest in Beam Therapeutics guide.You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.